Does LOPINAVIR Cause Hyperbilirubinaemia? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hyperbilirubinaemia have been filed in association with LOPINAVIR (Kaletra). This represents 0.6% of all adverse event reports for LOPINAVIR.
7
Reports of Hyperbilirubinaemia with LOPINAVIR
0.6%
of all LOPINAVIR reports
0
Deaths
2
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From LOPINAVIR?
Of the 7 reports, 2 (28.6%) required hospitalization.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOPINAVIR. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does LOPINAVIR Cause?
Foetal exposure during pregnancy (244)
Exposure during pregnancy (184)
Virologic failure (170)
Drug resistance (134)
Off label use (133)
Lipodystrophy acquired (126)
Premature baby (107)
Diplopia (89)
Treatment failure (89)
Premature delivery (88)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)
Which LOPINAVIR Alternatives Have Lower Hyperbilirubinaemia Risk?
LOPINAVIR vs LOPINAVIR\RITONAVIR
LOPINAVIR vs LOPRAZOLAM
LOPINAVIR vs LORATADINE
LOPINAVIR vs LORATADINE\PSEUDOEPHEDRINE
LOPINAVIR vs LORAZEPAM